Halozyme Therapeutics Inc (HALO.O) Analyst Research| Reuters.com
Edition:
United States

Halozyme Therapeutics Inc (HALO.O)

HALO.O on Nasdaq

8.44USD
24 Jun 2016
Change (% chg)

$-0.75 (-8.16%)
Prev Close
$9.19
Open
$8.71
Day's High
$9.10
Day's Low
$8.44
Volume
2,171,373
Avg. Vol
1,725,262
52-wk High
$25.25
52-wk Low
$6.96

Name Age Since Current Position

Kathryn Falberg

55 2015 Chairman of the Board

Helen Torley

53 2014 President, Chief Executive Officer, Director

Laurie Stelzer

48 2015 Chief Financial Officer, Senior Vice President

Harry Leonhardt

56 2015 Senior Vice President, Chief Compliance Officer, General Counsel

Athena Countouriotis

44 2015 Senior Vice President, Chief Medical Officer